Results 51 to 60 of about 15,300 (202)
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019–2021)
Oral Diseases, Volume 31, Issue 3, Page 993-1005, March 2025.ABSTRACT Objectives The aim of this study was to perform a descriptive analysis of oropharyngeal adverse events (AEs) related to drugs and/or vaccines in order to provide useful information for clinicians. Methods Data related to three regions of Italy were analyzed from 2019 to 2021 by using the National Pharmacovigilance database.
Liberata Sportiello +16 more
wiley +1 more source
Public policy for meningococcal vaccination [PDF]
Human Vaccines & Immunotherapeutics, 2018 On an individual basis, meningococcal disease is consistently shown to be one of the most feared potential childhood infections. On a population level, any clustering of cases or increase in disease requires proactive health protection management, while epidemics can be devastating.
openaire +3 more sources
Acta Paediatrica, Volume 114, Issue 1, Page 83-91, January 2025.Abstract Aim The burden of respiratory disease is great among children. This study aimed to examine the temporal relationship between hospitalisation for respiratory syncytial virus (RSV) and bacterial pneumonia. Methods A Swedish population‐based cohort was created by combining data from the Swedish Medical Birth Register, the National Inpatient ...
Karin Strandell +4 more
wiley +1 more source
Prevalence of de-O-acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom [PDF]
, 2000 Ray Borrow +3 more
openalex +2 more sources
Statistics of infections with diversity in the pathogenicity [PDF]
arXiv, 2004 The statistics of outbreaks in a model for the propagation of meningococcal diseases is analyzed, taking into account the possibility that the population is fragmented into weakly connected patches. It is shown that, depending on the size of of the sample studied, the ratio between the variance and the mean of infected cases can vary from one (Poisson ...
arxiv
Current opinion in investigational drugs (London, England : 2000), 2003 Neisseria meningitidis is one of the leading infectious causes of death in children under five years old in industrialized countries, and most cases can be attributed to five disease-causing serogroups: A, B, C, Y and W135. Meningococcal vaccine development began in the 1930s with killed whole-cell and exotoxin vaccines, but widespread use of ...
Collins, C, Pollard, A
openaire +2 more sources
Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines [PDF]
, 1983 E. C. Beuvery +3 more
openalex +1 more source
Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein [PDF]
, 1992 Peter van der Ley, Jan Poolman
openalex +1 more source
Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis. [PDF]
Vaccines (Basel), 2023 Conti A +5 more
europepmc +1 more source